Skin cancer is a worldwide, emerging clinical need in the elderly white population, with a
steady increase in incidence rates, morbidity and related medical costs. Skin cancer is a …

Purpose The American Society of Clinical Oncology (ASCO) and Society of Surgical
Oncology (SSO) sought to provide an evidence-based guideline on the use of lymphatic …

The vast majority of patients with newly diagnosed melanoma are “early‐stage”‐ie, clinically
localized to the primary cutaneous site. For such patients, surgery represents the mainstay of …

Purpose Completion lymph node dissection (CLND) following a positive sentinel lymph
node biopsy (SLNB) has been reported to be less morbid than lymphadenectomy for …

Sentinel node biopsy (SNB) is the most accurate staging tool for melanoma patients. The
procedure is indicated especially for intermediate thickness melanoma (pT2/3). SNB can be …

Background The benefit of completion lymph node dissection (CLND) in melanoma patients
with a positive sentinel lymph node (SLN) remains unknown. Methods We identified patients …

The incidence and mortality of cutaneous melanoma (CM) has increased over the last
decades in fair-skinned populations. Incidence and mortality, as well as rates of increase …

Background For patients with sentinel node-positive melanoma (SNPM), randomized trials,
first reported in 2015, found no benefit for routine completion lymph node dissection (CLND) …

Background Completion lymph node dissection (CLND), although considered a standard
approach for patients with melanoma and a positive sentinel lymph node (SLN), is not …

Introduction Inguinal lymphadenectomy for metastatic melanoma is reported to have a
complication rate as high as 50%. Wound dehiscence has been reported to occur in more …